Immune-Mediated Inflammatory Disorders (I.M.I.D.s): The Economic and Clinical Costs
New Developments in Influenza Vaccine Technology: A Potential New Prevention Strategy for Employers and Managed Care Organizations
Antibody-Targeted Chemotherapy for the Treatment of Relapsed Acute Myeloid Leukemia